Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 15 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-6.67 Insider Own2.00% Shs Outstand8.21M Perf Week-0.88%
Market Cap2.40M Forward P/E- EPS next Y-0.26 Insider Trans0.00% Shs Float8.05M Perf Month-3.24%
Income-6.13M PEG- EPS next Q-0.15 Inst Own3.32% Short Float3.64% Perf Quarter-5.99%
Sales0.06M P/S40.01 EPS this Y91.95% Inst Trans170.65% Short Ratio0.12 Perf Half Y-91.65%
Book/sh0.35 P/B0.83 EPS next Y63.38% ROA-219.26% Short Interest0.29M Perf Year-97.19%
Cash/sh0.26 P/C1.12 EPS next 5Y- ROE-337.53% 52W Range0.27 - 11.50 Perf YTD-90.86%
Dividend Est.- P/FCF- EPS past 5Y4.93% ROI-244.55% 52W High-97.46% Beta0.51
Dividend TTM- Quick Ratio2.08 Sales past 5Y32.45% Gross Margin-309.94% 52W Low9.60% ATR (14)0.02
Dividend Ex-Date- Current Ratio2.08 EPS Y/Y TTM56.05% Oper. Margin-8276.75% RSI (14)46.49 Volatility6.58% 6.19%
Employees4 Debt/Eq0.27 Sales Y/Y TTM-21.90% Profit Margin-10203.53% Recom1.00 Target Price1.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q81.52% Payout- Rel Volume0.04 Prev Close0.30
Sales Surprise0.00% EPS Surprise0.00% Sales Q/Q-60.29% EarningsMay 29 Avg Volume2.44M Price0.29
SMA20-0.83% SMA50-2.41% SMA200-87.74% Trades Volume105,377 Change-2.21%
Jul-09-24 07:00AM
Jun-26-24 08:30AM
Jun-25-24 08:30AM
Jun-20-24 08:00AM
Jun-18-24 07:00AM
10:55PM Loading…
May-15-24 10:55PM
Apr-29-24 09:00AM
Apr-25-24 09:14AM
Apr-23-24 08:00AM
Mar-04-24 08:00AM
Feb-27-24 03:22PM
Feb-26-24 09:15AM
Feb-05-24 08:00AM
Jan-29-24 09:31AM
09:17AM Loading…
Jan-26-24 07:58AM
Jan-22-24 08:00AM
Jan-17-24 08:00AM
Jan-08-24 08:00AM
Jan-02-24 12:00PM
Nov-27-23 08:00AM
Nov-08-23 08:00AM
Nov-06-23 08:00AM
Nov-01-23 08:00AM
Oct-25-23 08:30AM
Oct-24-23 08:45AM
Oct-23-23 07:00AM
Oct-02-23 08:00AM
Aug-25-23 04:10PM
11:27AM Loading…
Jun-14-23 11:27AM
Jun-08-23 07:30AM
May-30-23 07:30AM
May-23-23 07:30AM
May-19-23 07:30AM
May-11-23 12:41PM
May-02-23 07:00AM
Apr-28-23 11:20AM
Apr-24-23 07:00AM
Mar-07-23 09:19AM
Feb-16-23 07:00AM
Feb-15-23 07:00AM
Feb-05-23 08:50AM
Jan-31-23 10:01AM
Jan-17-23 08:29AM
Dec-22-22 10:36AM
Dec-21-22 10:23AM
Dec-19-22 08:33AM
Dec-01-22 09:41AM
Nov-16-22 05:12AM
Oct-25-22 07:00AM
Oct-24-22 07:00AM
Oct-12-22 07:00AM
Oct-10-22 07:05AM
Oct-03-22 07:03AM
Sep-19-22 07:03AM
Aug-04-22 07:00AM
Jul-22-22 09:01AM
Jul-20-22 07:00AM
Jun-22-22 07:00AM
Apr-26-22 09:15PM
Apr-21-22 07:45PM
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.